Screener
Pacira BioSciences, Inc. PCRX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $14,012 | $15,150 |
| Accrued expenses | 84,957 | 95,601 |
| Lease liabilities | 9,818 | 9,839 |
| Total current liabilities | 108,787 | 120,590 |
| Long-term debt, net | 367,656 | 372,189 |
| Lease liabilities | 33,705 | 36,176 |
| Contingent consideration | 15,789 | 18,066 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s operating lease liabilities (current)?
- Pacira BioSciences, Inc. (PCRX) reported operating lease liabilities (current) of $9.82M in Q1 2026.
- How has Pacira BioSciences, Inc.'s operating lease liabilities (current) changed year-over-year?
- Pacira BioSciences, Inc.'s operating lease liabilities (current) increased by 4.4% year-over-year, from $9.41M to $9.82M.
- What is the long-term trend for Pacira BioSciences, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s operating lease liabilities (current) has grown at a 5.8% compound annual growth rate (CAGR), from $7.43M to $9.84M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Pacira BioSciences, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude